Nuvalent (NUVL) Interest Expenses (2020 - 2026)

Nuvalent (NUVL) posted Interest Expenses of $465.5 million for Q1 2026, down 2.28% on a QoQ basis from $476.4 million in Q4 2025, and up 39.27% year-over-year from $334.3 million in Q1 2025.

Nuvalent (NUVL) Interest Expenses (2020 - 2026) Analysis & Trends

Nuvalent's Interest Expenses history runs 7 years deep, the most recent figure standing at $465.5 million for Q1 2026.

  • Quarterly Interest Expenses rose 39.27% year-over-year to $465.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $465.5 million (up 39.27% YoY) and the FY2025 annual result came in at $476.4 million, up 19.56% from the prior year.
  • Interest Expenses was $465.5 million for Q1 2026 at Nuvalent, down from $476.4 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $617.6 million in Q3 2024 and bottomed at $512000.0 in Q1 2023.
  • A 5-year average of $233.6 million and a median of $334.3 million in 2025 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2022 — Interest Expenses slumped 94.25% — and 2024, when it surged 47044.12%.
  • Nuvalent's Interest Expenses stood at $1.3 million in 2022, then jumped by 33312.86% to $449.4 million in 2023, then slipped by 11.35% to $398.4 million in 2024, then climbed by 19.56% to $476.4 million in 2025, then fell by 2.28% to $465.5 million in 2026.
  • Business Quant data shows NUVL's Interest Expenses at $465.5 million in Q1 2026, $476.4 million in Q4 2025, and $428.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Nuvalent 9.75 Bn 9.75 Bn - 465.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 465.51 Mn
Mar 31, 2026 465.51 Mn
Dec 31, 2025 476.36 Mn
Dec 31, 2025 476.36 Mn
Sep 30, 2025 428.90 Mn
Sep 30, 2025 428.90 Mn
Jun 30, 2025 360.93 Mn
Jun 30, 2025 360.93 Mn
Mar 31, 2025 334.26 Mn
Mar 31, 2025 334.26 Mn
Dec 31, 2024 398.41 Mn
Dec 31, 2024 398.41 Mn
Sep 30, 2024 617.59 Mn
Sep 30, 2024 617.59 Mn
Jun 30, 2024 430.98 Mn
Jun 30, 2024 430.98 Mn
Mar 31, 2024 1.39 Mn
Mar 31, 2024 1.39 Mn
Dec 31, 2023 449.40 Mn
Dec 31, 2023 449.40 Mn